BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis.

Details

Language :

English

ISSN :

20406207

Volume :

11

Database :

Complementary Index

Journal :

Therapeutic Advances in Hematology

Publication Type :

Academic Journal

Accession number :

173503406

Full Text :

https://doi.org/10.1177/2040620720932686